| Financial Year |
March 31 2023 |
| Monetary Funds |
2,123,161,594.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,415,196.85 |
| Accounts Receivable |
2,681,777,638.78 |
| Advances to Suppliers |
403,719,599.91 |
| Other Receivables |
87,186,576.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
396,077,049.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,841,834.11 |
| Total Current Assets |
11,135,687,573.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
39,902,662.62 |
| Fixed Assetes |
289,321,366.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,485,500.25 |
| R&D expenses |
-- |
| Goodwill |
33,602,619.24 |
| Long-Term Deferred and Prepaid Expenses |
6,597,996.73 |
| Deferred Income Tax Assets |
108,982,216.61 |
| Other Non-Current Assets |
2,967,959.00 |
| Sub-Total of Non-Current Assets |
539,202,138.16 |
| Total Assets |
11,674,889,711.48 |
| Short-Term Loans |
651,550,589.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,817,056.14 |
| Accounts Payable |
7,652,854,030.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,240,097.50 |
| Taxes Payable |
48,882,134.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,617,232.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,851,902.69 |
| Other Current Liabilities |
486,991,907.53 |
| Sub-Total of Current Liabilities |
10,530,947,183.81 |
| Long-term Loans |
106,576,627.92 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,407,462.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
218,888,556.09 |
| Total Liabilities |
10,749,835,739.90 |
| Paid-In Capital(Or Share Stock) |
208,056,700.00 |
| Capital Surplus |
7,057,537.22 |
| Surplus Reserve |
53,477,641.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
467,259,836.06 |
| Minority Stockholder's Interest |
148,840,436.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
776,213,535.54 |
| Owner's Equity（Stockholder's Equity） |
925,053,971.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,674,889,711.48 |
